Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Scholar Rock Holding buy melinda

Start price
€13.60
10.02.20 / 50%
Target price
€14.50
04.11.21
Performance (%)
76.47%
End price
€24.00
05.11.21
Summary
This prediction ended on 05.11.21 with a price of €24.00. The BUY prediction by melinda for Scholar Rock Holding saw massive gains of 76.47%. melinda has 50% into this prediction

Scholar Rock is a clinical-stage biopharmaceutical company that engages in the discovery and development of innovative medicines to treat serious diseases in patients that currently have limited or no treatment options. Their pipeline consists of a number of product candidates that target growth factor signaling pathways within the human body. These products hold potential for the treatment of multiple diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock, which trades under the symbol SRRK, is listed on the NASDAQ stock exchange.

Performance without dividends (%)
Name 1w 1m 1y 3y
Scholar Rock Holding 4.545% 4.545% 107.519% -
iShares Core DAX® 2.112% -0.367% 13.466% 16.854%
iShares Nasdaq 100 -2.197% -3.794% 38.426% 42.934%
iShares Nikkei 225® -1.555% -7.320% 18.451% 2.941%
iShares S&P 500 -0.472% -2.078% 27.488% 41.955%

Comments by melinda for this prediction

In the thread Scholar Rock Holding diskutieren
Prediction Buy
Perf. (%) 76.47%
Target price 14.500
Change
Ends at 04.11.21

Buy mit Kursziel 14,5

In the thread Trading Scholar Rock Holding
Prediction Buy
Perf. (%) 76.47%
Target price 14.500
Change
Ends at 04.11.21

Die von melinda gewählte maximale Laufzeit wurde überschritten